TherapeuticsMD, Inc.
TXMDDrug Manufacturers - Specialty & Generic
$1.83+2.23%As of Oct 29vs prior close
- Market cap
- $21.2M
- P/E (TTM)
- –
- P/E (FY1)
- 10.8×
- From 52W high
- −33.94%
- EPS (LTM)
- -$0.02
- Revenue (LTM)
- $3.3M
- Net margin
- -6.64%
Nomior Score
50
Steady ProfileTop 49% of the scored universe
Growth—
Quality34
Value—
Momentum82
Resilience38
Growth
−18.64%revenue a year over 9 fiscal years
YE16 $19.4MLTM $3.3M
Connections
Revenue to profitQ2 YE26
The operating loss was 94% of revenue, wider by 21 pts on a year.
Who owns it
1fund